BioSpace News Archive

PDS Biotechnology Corporation today announced that the company’s Chief Medical Officer, Dr. Lauren V. Wood, will be presenting at the upcoming 2021 International Head and Neck Cancer Conference

Novavax, Inc. (Nasdaq: NVAX), today announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for authorization of its COVID-19 vaccine candidate.

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it will release its third quarter 2021 financial results on Wednesday, November 10, 2021

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), is pleased to announce the appointment of Professor Ryan Donnelly, a world leader in the research and development of microneedle delivery technologies, as scientific and technical advisor for PharmaTher’s microneedle patch delivery programs involving controlled-substances such as ketamine and compounds treating infectious diseases.

Pasithea Therapeutics Corp. today announced that Pasithea Clinics, its wholly owned subsidiary, has administered intravenous (“IV”) ketamine therapy to its first patients.

Histogen Inc., a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, announced that Histogen’s financial results for the third quarter will be released after the close of market on Wednesday, November 10, 2021.

Apollo Endosurgery, Inc. today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2021 on Monday, November 1, 2021 after the market closes.

Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 third quarter operating results on Tuesday, November 9, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Pear Therapeutics and Thimble Point Acquisition Corp. Announce Effectiveness of S-4 Registration Statement and Set November 23, 2021 for Thimble Point Special Stockholder Meeting to Vote on Proposed Business Combination

Sera Prognostics Inc., today announced that it will report third quarter 2021 financial results on Tuesday, November 9, 2021 , after the close of the market.